Retinoblastoma management remains complex, requiring individualized treatment based on
International Classification of Retinoblastoma (ICRB) staging, germline mutation status …

Retinoblastoma is a rare cancer of the infant retina that is diagnosed in approximately 8,000
children each year worldwide. It forms when both retinoblastoma gene (RB1) alleles are …

Retinoblastoma is lethal by metastasis if left untreated, so the primary goal of therapy is to
preserve life, with ocular survival, visual preservation and quality of life as secondary aims …

The management of intraocular retinoblastoma is rapidly changing, and even recent reviews
on the subject are behind existing practices. The 4 authors of this report collectively …

Objective To analyze our 5-year experience of intra-arterial chemotherapy (IAC) for
retinoblastoma as primary or secondary therapy. Design Retrospective interventional case …

With an average incidence of 1 in every 18,000 live births, retinoblastoma is a rare type of
intraocular tumour found to affect patients during their early childhood. It is curable if …

In this report, we explore retinoblastoma diagnostic accuracy and review chemotherapy
alternatives for retinoblastoma using intravenous, intra-arterial, periocular, and intravitreal …

Targeted retinoblastoma management: when to use intravenous,... : Current Opinion in
Ophthalmology Targeted retinoblastoma management: when to use intravenous, intra-arterial …

This report presents the recommendations of the WHO Expert Committee responsible for
updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to …

Abstract Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery
chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment …